<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Dermoscopy Techniques &amp; Clinical Studies Archives - MoleMax Systems</title>
	<atom:link href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Provide the best skin imaging device</description>
	<lastBuildDate>Sun, 01 Nov 2026 10:52:06 +0000</lastBuildDate>
	<language>en-AU</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://molemaxsystems.com/wp-content/uploads/2020/10/favicon.png</url>
	<title>Dermoscopy Techniques &amp; Clinical Studies Archives - MoleMax Systems</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>How Much Does a Dermatoscope Cost in Australia? A Clinic Buying Guide</title>
		<link>https://molemaxsystems.com/how-much-does-a-dermatoscope-cost-in-australia-a-clinic-buying-guide/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Sun, 01 Nov 2026 10:52:06 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[Digital Dermoscopy & Skin Imaging]]></category>
		<category><![CDATA[dermatoscope]]></category>
		<category><![CDATA[dermatoscope australia]]></category>
		<category><![CDATA[Dermatoscope benefits]]></category>
		<category><![CDATA[dermoscopy]]></category>
		<category><![CDATA[DL4]]></category>
		<category><![CDATA[DL5]]></category>
		<category><![CDATA[Use of the Dermatoscope]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12419</guid>

					<description><![CDATA[<p>Explore the factors affecting dermatoscope prices, from optical quality and illumination modes to imaging accessories, maintenance and servicing. Learn how to compare equipment options and choose the right dermatoscope for your medical practice.</p>
<p>The post <a href="https://molemaxsystems.com/how-much-does-a-dermatoscope-cost-in-australia-a-clinic-buying-guide/">How Much Does a Dermatoscope Cost in Australia? A Clinic Buying Guide</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Dermatoscope costs in Australia vary by device, included accessories, and clinical workflow. The difference is not just branding. Optical quality, illumination options, power systems, imaging accessories, local support and whether the instrument is part of a wider digital documentation workflow all influence the eventual bill.</p>
<p>For a medical practice, the useful question is not simply “What is the cheapest dermatoscope?” It is “What equipment and support do we need for the examinations we perform?” This guide explains typical purchasing tiers, the costs that are easy to overlook and how to compare quotes consistently.</p>
<p>Pricing note: MoleMax Systems pricing, model availability, GST treatment and package inclusions should be confirmed directly through the MoleMax dermatoscope range or a current MoleMax quotation. This guide does not publish unverified prices.</p>
<h2>Dermatoscope costs in Australia at a glance</h2>
<p>The cost depends on the equipment category and what the clinic needs to accomplish. Use this comparison to define a suitable quotation rather than treating an isolated sticker price as the total investment.</p>
<div>
<div>
<table>
<tbody>
<tr>
<th>Equipment type</th>
<th>Key cost considerations</th>
<th>MoleMax next step</th>
</tr>
<tr>
<td>Entry-level handheld dermatoscope</td>
<td>Core illumination, optical design, power source and included accessories</td>
<td>Check the MoleMax dermatoscope range for currently available options</td>
</tr>
<tr>
<td>Versatile handheld dermatoscope</td>
<td>Polarised/non-polarised viewing, contact options, ergonomics and charging</td>
<td>Request a model-specific quote and list of inclusions</td>
</tr>
<tr>
<td>Advanced handheld dermatoscope</td>
<td>Additional illumination controls, capture compatibility, accessories and daily-use convenience</td>
<td>Review the DermLite DL5 product page and confirm the current configuration</td>
</tr>
<tr>
<td>Digital skin-imaging or mole-mapping platform</td>
<td>Hardware, software, implementation, documentation workflow, training and support</td>
<td>Consult the MoleMax system pricing guide and request a configuration-specific quote</td>
</tr>
</tbody>
</table>
</div>
</div>
<p>No single price suits every clinic. Compare itemised quotations on a consistent GST-inclusive basis, including accessories and any implementation costs. Contact MoleMax Systems for current pricing.</p>
<h2>Why do dermatoscope prices vary?</h2>
<h3>1. Optical design and viewing experience</h3>
<p>A dermatoscope must provide suitable magnification and illumination for visual examination. Two instruments may both advertise approximately 10× magnification yet differ in field of view, optical ergonomics, working distance and how comfortably they can be used during a full clinic session.</p>
<p>Do not compare optical specifications on magnification alone. Assess whether the clinician can clearly examine the structures relevant to their practice, including the practical advantages of a larger viewing area. Hands-on evaluation is valuable where possible.</p>
<h3>2. Polarised, non-polarised and variable illumination</h3>
<p>Polarised dermoscopy can reduce surface reflections without requiring an immersion medium in many examinations. Non-polarised contact dermoscopy may show some superficial structures differently. Hybrid or variable-polarisation designs let clinicians choose the mode most appropriate to the examination.</p>
<p>Advanced illumination adds expense, but it does not remove the need for training or clinical judgement. A feature is valuable when the team knows when and why it will be used, not merely because it appears on the specification sheet.</p>
<p>For more on selecting examination modes, see Which Dermatoscope Should I Use?.</p>
<h3>3. Rechargeable batteries and charging accessories</h3>
<p>Check what is included with the advertised instrument. A desk charging base, replacement charging components and the practicality of charging between consultations can affect everyday use. A lower sticker price can become less attractive if required accessories are separate.</p>
<h3>4. Smartphone imaging and clinical documentation</h3>
<p>Taking an image through a handheld dermatoscope is different from operating a complete patient imaging record. Smartphone adapters, supported devices and capture workflows should be confirmed before purchase. Some practices may need more structured follow-up documentation, repeatable photography or image management rather than a standalone handheld device.</p>
<p>Ask where photographs will be stored, how they will be linked to a patient record and whether the solution fits local privacy, clinical governance and record-retention obligations. Avoid storing identifiable patient images in unapproved personal accounts or galleries.</p>
<h3>5. Supplier support, servicing and replacement arrangements</h3>
<p>Clinical equipment can be inexpensive to buy yet disruptive when it is unavailable. Compare the written warranty, local service availability, repairs, expected turnaround and whether temporary replacement equipment is offered. Do not assume that all sellers provide identical terms for the same model.</p>
<h2>What does a clinic actually need to budget for?</h2>
<p>A sensible dermatoscope budget has three layers:</p>
<ul>
<li>
<div>
<div>
<p>The device: model, viewing modes, optics and included power equipment.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>The working setup: any contact plates, infection-control supplies, adapters, carrying protection and documentation accessories needed by the practice.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>Ownership and operation: training, servicing, repairs, replacement parts, software if used, and time spent managing images and records.</p>
</div>
</div>
</li>
</ul>
<p>This matters when a clinic is choosing between buying a portable examination instrument and investing in a broader imaging workflow. A handheld dermatoscope primarily supports close visual examination. Digital dermoscopy and total-body or regional imaging systems can also support documentation and longitudinal comparison, depending on the configuration. These are different purchases with different operating requirements.</p>
<p>For a larger implementation, MoleMax provides a system pricing guide covering configurable options and add-ons. Seek a complete quotation rather than assuming a single retail hardware price captures the cost of deployment.</p>
<h2>Which dermatoscope price tier fits your clinic?</h2>
<h3>General practice beginning routine dermoscopy</h3>
<p>Prioritise a reliable instrument, clear viewing, comfortable handling and access to appropriate training. A compact device may be sufficient when examinations are relatively occasional and structured image documentation is handled separately.</p>
<p>Choose the illumination capability your clinicians are trained to use. Budget for cleaning procedures and the accessories actually needed, not every optional attachment.</p>
<h3>Dedicated skin-cancer clinic with frequent examinations</h3>
<p>Daily use makes ergonomics, convenient charging, versatile lighting and straightforward instrument maintenance more important. An advanced hybrid device may justify its higher acquisition cost where the additional modes and accessories are regularly used.</p>
<p>The DermLite DL5 is an example of a feature-rich handheld option. MoleMax&#8217;s product information lists 10× optics, a 32 mm lens system, variable polarisation, 365 nm UV illumination, a rechargeable battery and an included smartphone adapter. Confirm the latest package inclusions, compatibility and support terms on the actual quotation.</p>
<h3>Clinic monitoring many high-risk patients over time</h3>
<p>Consider whether the practice requires repeatable photographs, lesion localisation, longitudinal comparison and a defined image-review workflow. Buying a more advanced handheld instrument alone does not create a complete digital monitoring system.</p>
<p>Digital imaging investment should be evaluated by its workflow and clinical governance requirements. Assess capacity, staff training, data management, integration and service—not just the camera resolution or purchase price. Decisions about which patients benefit from monitoring remain clinician-led.</p>
<h3>Multi-clinician or expanding practice</h3>
<p>Standardising device models and documentation procedures may make training and supplies simpler. Before ordering multiple instruments, determine whether each clinician needs an individual unit, whether rooms share equipment safely and how imaging records are accessed across consulting spaces.</p>
<h2>Five questions to ask before accepting a dermatoscope quote</h2>
<ol>
<li>
<div>
<div>
<p>What exactly is included? Compare the main unit, charging equipment, contact accessories, imaging adaptors and carrying case line by line.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>Is the quoted amount GST-inclusive? Ask the supplier to show the GST treatment clearly and identify shipping charges where relevant.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>Does the device support how we examine patients? Assess polarisation modes, handling, battery routine and whether smartphone imaging is genuinely necessary.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>How will images and patient information be managed? If documentation is required, confirm compatibility, user permissions, approved storage and ongoing responsibilities.</p>
</div>
</div>
</li>
<li>
<div>
<div>
<p>What happens if the device fails? Request written warranty and service information, including repair arrangements and any exclusions.</p>
</div>
</div>
</li>
</ol>
<p>A quote comparison sheet can help practices score these factors rather than selecting the lowest number in a price column.</p>
<h2>A simple total-cost example</h2>
<p>Consider two hypothetical purchasing options over three years. The following values are illustrative arithmetic, not live offers or vendor claims:</p>
<div>
<div>
<table>
<tbody>
<tr>
<th>Example budget item</th>
<th>Basic setup</th>
<th>Advanced setup</th>
</tr>
<tr>
<td>Device</td>
<td>A$700</td>
<td>A$2,500</td>
</tr>
<tr>
<td>Accessories</td>
<td>A$100</td>
<td>A$250</td>
</tr>
<tr>
<td>Replacement/maintenance allowance</td>
<td>A$100</td>
<td>A$150</td>
</tr>
<tr>
<td>Three-year illustrative total</td>
<td>A$900</td>
<td>A$2,900</td>
</tr>
</tbody>
</table>
</div>
</div>
<p>The example deliberately excludes staff time, training, software, practice integration and any financing costs; those could materially change the result. It shows why the comparison should cover the entire working setup, not just the initial hardware line.</p>
<p>An instrument does not need to be the most expensive to be clinically appropriate. The goal is equipment suited to the clinician&#8217;s training, patient population and intended workflow.</p>
<h2>Dermatoscope cost FAQs</h2>
<h3>How much does a dermatoscope cost in Australia?</h3>
<p>Pricing varies by model, illumination features, accessories and whether the clinic needs an integrated imaging system. For an accurate Australian-dollar figure, review the MoleMax dermatoscope range and request an itemised, GST-inclusive quotation for the exact setup.</p>
<h3>Is a more expensive dermatoscope always better?</h3>
<p>No. Higher-priced models may offer advanced optics, illumination modes, accessories or convenience features. Those advantages matter only if they are relevant to the clinic and clinicians know how to use them. Training and clinical workflow remain essential.</p>
<h3>Are a dermatoscope and a mole-mapping system the same purchase?</h3>
<p>No. A handheld dermatoscope supports magnified examination of lesions. Mole-mapping or digital imaging systems may provide wider photographic documentation, image management and repeat-visit comparisons. Their hardware, software and implementation requirements differ.</p>
<h3>Do I need to buy a smartphone attachment?</h3>
<p>Not necessarily. Smartphone attachment is useful if your clinic has an approved image-capture workflow and a compatible device. For direct examination without image capture, it may not be required. Verify exact phone and case compatibility before ordering.</p>
<h3>How often should a clinic replace its dermatoscope?</h3>
<p>There is no universal replacement interval. Review image quality, lighting, battery and mechanical condition, infection-control requirements, servicing availability and evolving clinical needs. Follow manufacturer guidance and local equipment-management policies.</p>
<h3>Can dermoscopy replace a biopsy?</h3>
<p>No. Dermoscopy is an aid to clinical assessment; suspicious lesions still require appropriate clinician-led investigation and, when indicated, histopathological evaluation. Equipment cost should never determine whether an indicated investigation proceeds.</p>
<h2>Compare equipment by clinical fit, not only purchase price</h2>
<p>A good dermatoscope buying decision balances optical performance, illumination, daily usability, image documentation and support. Entry-level handheld devices can serve routine examinations, while advanced instruments offer additional modes and conveniences. Practices that require long-term imaging should assess the larger system separately.</p>
<p>Review the MoleMax DermLite dermatoscope range for available models and request an itemised quotation for the configuration suited to your clinic. For integrated imaging, the MoleMax pricing guide provides the appropriate starting point.</p>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/how-much-does-a-dermatoscope-cost-in-australia-a-clinic-buying-guide/">How Much Does a Dermatoscope Cost in Australia? A Clinic Buying Guide</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dermoscopic and Histopathological Features of Melanocytic Lesions in Melanoma Patients Undergoing Adjuvant Systemic Therapy</title>
		<link>https://molemaxsystems.com/dermoscopic-and-histopathological-features-of-melanocytic-lesions-in-melanoma-patients-undergoing-adjuvant-systemic-therapy/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Wed, 28 Oct 2026 01:10:17 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[dematology research]]></category>
		<category><![CDATA[melanoma]]></category>
		<category><![CDATA[skin cancer]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12394</guid>

					<description><![CDATA[<p>Melanoma accounts for around 1% of all skin tumors yet is responsible for 80% of deaths related to skin cancer. Although adjuvant therapies improve survival, their effects on nevi remain unclear.</p>
<p>The post <a href="https://molemaxsystems.com/dermoscopic-and-histopathological-features-of-melanocytic-lesions-in-melanoma-patients-undergoing-adjuvant-systemic-therapy/">Dermoscopic and Histopathological Features of Melanocytic Lesions in Melanoma Patients Undergoing Adjuvant Systemic Therapy</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
		<div id="fws_6af74c5e7814d"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row top-level"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<nav role="none">Huseyin Berk Yalcin, Kerem Balan, Ozay Gokoz, Gonca Elcin, Omer Dizdar, Saadettin Kılıckap, Duygu Gulseren</nav>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6af74c5e792e4"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p><strong>Introduction</strong>: Melanoma accounts for around 1% of all skin tumors yet is responsible for 80%<br />
of deaths related to skin cancer. Although adjuvant therapies improve survival, their effects on nevi<br />
remain unclear.</p>
<p><strong>Objectives</strong>: This study aimed to investigate the dermoscopic and histopathological features of mela-<br />
nocytic nevi in melanoma patients receiving adjuvant systemic therapy.</p>
<p><strong>Methods</strong>: Dermoscopic images of 1,299 melanocytic nevi from 25 melanoma patients undergoing<br />
adjuvant therapy (targeted therapy, immunotherapy, or IFN-α) were analyzed before and after treat-<br />
ment. The histopathological features of 129 excised nevi from 67 melanoma patients were compared<br />
between patients who received adjuvant therapy and those who did not.</p>
<p><strong>Results</strong>: Melanoma patients on targeted therapy showed a greater reduction in global pigmentation<br />
and disappearance of the pigment network than those on IFN-α and immunotherapy (p=0.001 and<br />
P=0.017, respectively). IFN-α therapy was associated with more atypical pigment network changes<br />
than targeted therapy and immunotherapy (P=0.027). Histopathologically, structural atypia, cytolog-<br />
ical atypia, inflammation, and fibroplasia were more prevalent in excised nevi from patients receiving<br />
adjuvant therapy (P=0.003, P=0.004, P&lt;0.001, P=0.020, respectively).</p>
<p><strong>Conclusions</strong>: Adjuvant systemic therapy induces dermoscopic and histopathological changes in<br />
melanocytic nevi. Clinicians and pathologists should carefully consider these alterations during mela-<br />
noma follow-up to inform treatment decisions.</p>
<p>To read further on this article please <a href="https://mail.dpcj.org/index.php/dpc/article/view/5814/3729" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/dermoscopic-and-histopathological-features-of-melanocytic-lesions-in-melanoma-patients-undergoing-adjuvant-systemic-therapy/">Dermoscopic and Histopathological Features of Melanocytic Lesions in Melanoma Patients Undergoing Adjuvant Systemic Therapy</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Unmasking Facial Melanosis: A Prospective Clinico-Dermoscopic Study</title>
		<link>https://molemaxsystems.com/unmasking-facial-melanosis-a-prospective-clinico-dermoscopic-study/</link>
		
		<dc:creator><![CDATA[Karen Hanni]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 02:29:39 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[dematology research]]></category>
		<category><![CDATA[dermoscopy]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12229</guid>

					<description><![CDATA[<p>Various entities of acquired facial melanosis present with considerable clinical overlap, posing diagnostic challenges. Dermoscopy is being increasingly used in its diagnosis.</p>
<p>The post <a href="https://molemaxsystems.com/unmasking-facial-melanosis-a-prospective-clinico-dermoscopic-study/">Unmasking Facial Melanosis: A Prospective Clinico-Dermoscopic Study</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
		<div id="fws_6af74c5e7b30d"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p>Sheethal K Jose, Priya Sara Kuryan, Diya Katrina Koikkara, Gauri Dinesh Mahabal, Leni George, Dincy Peter C.V, Susanne A. Pulimood, Meera Thomas</p>
<p>Department of Dermatology Venereology and Leprosy, Christian Medical College, Vellore, India<br />
Department of Pathology, Christian Medical College, Vellore, India</p>
<h3 class="_label"><strong>Abstract</strong></h3>
<p><strong>Introduction: </strong>Various entities of acquired facial melanosis present with considerable clinical overlap, posing diagnostic challenges. Dermoscopy is being increasingly used in its diagnosis.</p>
<p><strong>Objectives: </strong>To assess dermoscopic and clinicopathological features of facial melanosis in Fitzpatrick skin types IV-VI.</p>
<p><strong>Methods: </strong>A cross-sectional study of clinical and dermoscopic features of facial melanosis—lichen planus pigmentosus (LPP), pigmented contact dermatitis (PCD), and facial acanthosis nigricans (FAN)—was conducted. Melasma, periorbital hyperpigmentation, and nevus of Ota were excluded.</p>
<p>To read more on this article and review the results please visit <a href="https://dpcj.org/index.php/dpc/article/view/7032/3924" target="_blank" rel="noopener">Dermatology Practical &amp; Conceptual</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/unmasking-facial-melanosis-a-prospective-clinico-dermoscopic-study/">Unmasking Facial Melanosis: A Prospective Clinico-Dermoscopic Study</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </title>
		<link>https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Fri, 02 Oct 2026 10:10:41 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[basal cell carcinoma dermoscopy]]></category>
		<category><![CDATA[junctional nevus]]></category>
		<category><![CDATA[melanoma]]></category>
		<category><![CDATA[melanosis]]></category>
		<category><![CDATA[skin lesion evaluation]]></category>
		<category><![CDATA[Spitz naevus]]></category>
		<category><![CDATA[subungual melanoma]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=12137</guid>

					<description><![CDATA[<p>A clinical framework for evaluating skin lesions with dermoscopy patterns, pitfalls, and when to biopsy.</p>
<p>The post <a href="https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/">Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Every skin check comes down to one question: is this lesion benign, or does it need action? Reliable skin lesion evaluation is what separates confident practice from guesswork, and dermoscopy is what makes it repeatable  revealing sub-surface structures and vascular patterns that turn subjective pattern recognition into a structured assessment. </p>



<p class="wp-block-paragraph">This guide is an overview: it covers the evaluation framework and several lesion types that don&#8217;t yet have a dedicated deep-dive on this site  junctional nevus vs. melanoma, melanosis, subungual melanoma, and Spitz naevus  and links out to our fuller guides on basal cell carcinoma, acral lesions, the 7-point checklist, and mole mapping where those already exist. </p>



<h2 class="wp-block-heading"><strong>What Skin Lesion Evaluation Involves</strong> </h2>



<p class="wp-block-paragraph">Good skin lesion evaluation combines the clinical picture  history, change over time, and patient risk factors with a magnified dermoscopic view. Dermoscopy adds a second layer of information: pigment network, vessels, colours, and specific structures that correlate with particular diagnoses. The goal is not to replace histology but to decide, with far greater accuracy, which lesions can be reassured, which need monitoring, and which require biopsy. </p>



<h2 class="wp-block-heading"><strong>A Structured Approach to Reading Lesions</strong> </h2>



<p class="wp-block-paragraph">Experienced clinicians rarely assess a lesion at random. A common method is the two-step approach: first decide whether a lesion is melanocytic or non-melanocytic, then apply the relevant criteria for that category. This is followed by pattern analysis weighing symmetry, the regularity of the pigment network, the number of colours, and any melanoma-specific structures. Working through a lesion in this order reduces the chance of anchoring on a single feature and missing the bigger picture. </p>



<h2 class="wp-block-heading"><strong>Junctional Nevus vs. Melanoma</strong> </h2>



<p class="wp-block-paragraph">One of the most common diagnostic questions is junctional nevus vs. melanoma. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td> </td>
<td><strong>Junctional nevus (benign)</strong> </td>
<td><strong>Melanoma</strong> </td>
</tr>
<tr>
<td>Pigment network </td>
<td>Regular, symmetric, even colour </td>
<td>Atypical or broadened, often asymmetric </td>
</tr>
<tr>
<td>Colours </td>
<td>Usually one or two </td>
<td>Often three or more </td>
</tr>
<tr>
<td>Structures </td>
<td>None of concern </td>
<td>Irregular streaks, blue-white structures </td>
</tr>
<tr>
<td>Overall pattern </td>
<td>Symmetric </td>
<td>Asymmetric </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">The overlap between the two is exactly why structured scoring matters. Applying a framework such as the <a href="https://molemaxsystems.com/7-point-checklist-for-melanoma-a-complete-dermoscopy/" target="_blank" rel="noopener">7-Point Checklist for Melanoma</a> helps quantify suspicious features rather than relying on impression alone, and digital monitoring adds the dimension of change over time often the deciding factor for a borderline lesion that looks stable on a single visit. </p>



<h2 class="wp-block-heading"><strong>Melanosis and Pigmented Lesions</strong> </h2>



<p class="wp-block-paragraph">Melanosis and other flat pigmented lesions present their own evaluation challenge, particularly on sun-damaged skin and mucosal surfaces where benign pigmentation and early melanoma can look alike. Dermoscopy helps by revealing whether the pigment follows a regular, structured pattern or an irregular, chaotic one, and whether specific worrying structures are present. </p>



<p class="wp-block-paragraph">Documenting these lesions is especially valuable, because subtle change is often the earliest sign that a stable-looking pigmented area needs review. A baseline image gives the clinician something concrete to compare against at the next visit, rather than relying on memory. </p>



<h2 class="wp-block-heading"><strong>Subungual Melanoma: Reading the Nail</strong> </h2>



<p class="wp-block-paragraph">Few findings cause more anxiety than a pigmented streak in the nail. Subungual melanoma is rare but serious, and it is frequently mistaken for benign melanonychia or a simple haematoma. Dermoscopy of the nail assesses the colour, width, spacing, and regularity of the pigmented band, along with any pigment extending onto the surrounding skin Hutchinson&#8217;s sign, an important warning sign. </p>



<p class="wp-block-paragraph">A widely used screening framework, the ABCDEF rule for subungual melanoma, adds nail-specific criteria age, band breadth and border irregularity, change, digit involved, extension onto skin, and family history — to the general ABCDE approach. Any irregular, broadening, or multicoloured band warrants specialist referral. Cancer Council Australia emphasises that early detection is decisive for melanoma outcomes, and the nail is one site where delayed diagnosis is unfortunately common. When in doubt, referral and biopsy are the safe path. </p>



<h2 class="wp-block-heading"><strong>Spitz Naevus and Other Look-Alikes</strong> </h2>



<p class="wp-block-paragraph">Some benign lesions are notorious for imitating melanoma. Spitz naevus, most common in children and young adults, can show a striking starburst or globular pattern that overlaps with melanoma-specific features. In adults especially, a lesion with spitzoid features is usually excised rather than monitored, because the dermoscopic distinction from melanoma is not reliable enough to justify watchful waiting. Knowing these traps prevents both false reassurance and unnecessary alarm. </p>



<h2 class="wp-block-heading"><strong>Colours Under Dermoscopy and What They Mean</strong> </h2>



<p class="wp-block-paragraph">Colour is one of the most information-rich signals in skin lesion evaluation, because it effectively reports the depth of the pigment. </p>



<figure class="wp-block-table">
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Colour</strong> </td>
<td><strong>What it indicates</strong> </td>
</tr>
<tr>
<td>Black </td>
<td>Melanin in the upper epidermis </td>
</tr>
<tr>
<td>Brown </td>
<td>Melanin in the deeper epidermis </td>
</tr>
<tr>
<td>Grey or blue </td>
<td>Melanin in the dermis </td>
</tr>
<tr>
<td>Red or pink </td>
<td>Vascularity </td>
</tr>
<tr>
<td>White </td>
<td>Regression or scarring </td>
</tr>
<tr>
<td>Yellow </td>
<td>Keratin or sebaceous material </td>
</tr>
</tbody>
</table>
</figure>



<p class="wp-block-paragraph">A key rule of thumb: the more colours present in a single lesion, the greater the concern. A uniformly brown lesion is usually reassuring, whereas a lesion showing three or more colours  particularly blue-white or grey  deserves closer scrutiny and, often, biopsy. </p>



<h2 class="wp-block-heading"><strong>Benign Mimics Worth Knowing</strong> </h2>



<p class="wp-block-paragraph">Not every alarming-looking lesion is dangerous. Seborrhoeic keratoses, for example, are extremely common benign lesions that can appear dark and irregular yet show reassuring dermoscopic features  milia-like cysts, comedo-like openings, and a brain-like surface. Recognising these benign patterns confidently is as important as spotting malignant ones: it prevents unnecessary excisions and reassures patients. </p>



<h2 class="wp-block-heading"><strong>Common Pitfalls to Avoid</strong> </h2>



<ul class="wp-block-list">
<li>Relying on a single feature rather than the overall pattern. </li>
</ul>



<ul class="wp-block-list">
<li>Examining a lesion under too much pressure, blanching its vessels and losing the vascular information. </li>
</ul>



<ul class="wp-block-list">
<li>Under-calling amelanotic and nodular melanomas, which lack the classic pigment cues  any firm, growing, or bleeding lesion deserves suspicion regardless of colour. </li>
</ul>



<ul class="wp-block-list">
<li>Failing to document a borderline lesion, which removes the option of comparison later  arguably the most valuable tool a clinician has. </li>
</ul>



<h2 class="wp-block-heading"><strong>Combining the ABCDE Rule with Dermoscopy</strong> </h2>



<p class="wp-block-paragraph">The naked-eye ABCDE rule  Asymmetry, Border irregularity, Colour variation, Diameter over 6mm, and Evolution  remains a useful first filter, especially for patients performing self-examination. Dermoscopy builds on it rather than replacing it: where ABCDE flags a lesion as potentially concerning, dermoscopy interrogates the same lesion at a structural level, confirming or downgrading the suspicion. The two work best together  ABCDE catches the clinician&#8217;s attention, and dermoscopy refines the decision that follows. </p>



<p class="wp-block-paragraph">The &#8220;E&#8221; for evolution deserves particular emphasis, because change over time is the most reliable single indicator of malignancy, and it is precisely what digital documentation captures better than memory ever could. </p>



<h2 class="wp-block-heading"><strong>Basal Cell Carcinoma Dermoscopy</strong> </h2>



<p class="wp-block-paragraph">Basal cell carcinoma dermoscopy is one of the clearest success stories for the technique  arborising vessels, blue-grey ovoid nests, leaf-like areas, and spoke-wheel structures make BCC one of the more recognisable tumours under the dermatoscope, and help distinguish it from benign pink lesions such as intradermal naevi or sebaceous hyperplasia. </p>



<p class="wp-block-paragraph">For the full feature set and how subtype patterns guide treatment choice, see <a href="https://molemaxsystems.com/clinical-and-dermoscopic-characterization-of-mixed-type-basal-cell-carcinoma/" target="_blank" rel="noopener">Clinical and Dermoscopic Characterization of Mixed-Type Basal Cell Carcinoma</a>. </p>



<h2 class="wp-block-heading"><strong>Acral Lesions: Palms and Soles</strong> </h2>



<p class="wp-block-paragraph">Lesions on the palms and soles follow their own dermoscopic rules because of the ridged skin found there: benign acral naevi typically show pigment along the furrows (the parallel-furrow pattern), whereas acral melanoma more often shows pigment on the ridges (the parallel-ridge pattern). </p>



<p class="wp-block-paragraph">For the evidence behind this distinction and the fuller set of acral patterns, see <a href="https://molemaxsystems.com/diagnostic-accuracy-of-dermoscopic-features-in-acral-lentiginous-melanoma/" target="_blank" rel="noopener">Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma</a> and <a href="https://molemaxsystems.com/dermoscopic-features-of-acral-palmoplantar-nevi-age-and-site-correlation-in-a-north-african-cohort/" target="_blank" rel="noopener">Dermoscopic Features of Acral Palmoplantar Nevi</a>. Any irregular or broad pigmentation on these sites still warrants careful assessment regardless of pattern. </p>



<h2 class="wp-block-heading"><strong>Documentation and Monitoring Over Time</strong> </h2>



<p class="wp-block-paragraph">Across every lesion type above, the single biggest advantage of modern practice is the ability to compare images over time. A digital dermoscopy system such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noopener">MoleMax HD</a>, paired with a quality <a href="https://molemaxsystems.com/product-category/dermlite/dermatoscopes/" target="_blank" rel="noopener">DermLite dermatoscope</a>, lets clinicians capture a lesion today and re-examine the exact same site months later. </p>



<p class="wp-block-paragraph">For how total body photography and change tracking fit together, see <a href="https://molemaxsystems.com/mole-mapping-technology-what-it-is-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">Mole Mapping Technology</a>; for how AI-assisted analysis adds a further layer of change detection, see <a href="https://molemaxsystems.com/ai-skin-cancer-detection-system-how-it-works-and-why-clinics-are-adopting-it/" target="_blank" rel="noopener">AI Skin Cancer Detection System</a>. </p>



<h2 class="wp-block-heading"><strong>Building Dermoscopy into Routine Practice</strong> </h2>



<p class="wp-block-paragraph">The clinics that get the most from dermoscopy are those that make it routine rather than occasional. Photographing lesions consistently, storing images in a searchable record, and reviewing them at each visit turns a one-off examination into genuine longitudinal care  more than any single feature, that habit drives earlier detection and better outcomes. </p>



<p class="wp-block-paragraph">Skill also grows with reference and repetition. Comparing uncertain lesions against curated image libraries such as Dermoscopedia and DermNet steadily sharpens pattern recognition, and combining that study with a consistent imaging workflow is the fastest way for a clinic to raise the quality of its skin lesion evaluation across every practitioner on the team. </p>



<h2 class="wp-block-heading"><strong>Bring Structure to Your Skin Checks</strong> </h2>



<p class="wp-block-paragraph">The clearest way to see how digital dermoscopy fits your workflow is a live walkthrough. <a href="https://molemaxsystems.com/online-demo-request" target="_blank" rel="noopener">Book a free 15-minute MoleMax demo</a> and our specialist team will show you high-resolution capture, lesion tracking, side-by-side comparison, and structured reporting on real cases  and answer any questions specific to your practice. </p>



<p class="wp-block-paragraph">&nbsp;</p>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/dermoscopy-skin-lesion-evaluation/">Skin Lesion Evaluation with Dermoscopy: A Clinical Guide </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</title>
		<link>https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Thu, 20 Aug 2026 00:04:44 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[dematology research]]></category>
		<category><![CDATA[Dermatoscope benefits]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11656</guid>

					<description><![CDATA[<p>The dermatoscopic appearance of scalp tumors, especially melanocytic scalp lesions, differs from that on other body areas.</p>
<p>The post <a href="https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/">The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6af74c5e805a3"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<ul class="authors">
<li><span class="name">Hatice Gamze Demirdag</span><span class="affiliation">Acıbadem İzmir Kent Hospital, Department of Dermatology, İzmir, Turkiye</span></li>
<li><span class="name">Elif Demirci Saadet</span><span class="affiliation">Atılım University School of Medicine, Medicana International Ankara Hospital, Department of Dermatology, Ankara, Turkiye</span></li>
</ul>
<h3 class="_label"><strong>Abstract</strong></h3>
<p><strong>Introduction: </strong>The dermatoscopic appearance of scalp tumors, especially melanocytic scalp lesions, differs from that on other body areas. Few studies have revealed the dermatoscopic characteristics of scalp nevi.</p>
<p><strong>Objectives:</strong> This study aimed to establish the clinical and dermatoscopic features of scalp nevi in adults and to compare dermatoscopic patterns according to the demographic and clinical features.</p>
<p><strong>Methods:</strong> This prospective study included 129 adult patients with 253 nevi. Demographic data of patients, clinical characteristics, and dermatoscopic features were recorded and compared.</p>
<p>To read more on this article please <a href="https://dpcj.org/index.php/dpc/article/view/6726" target="_blank" rel="noopener">click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/the-evaluation-of-clinical-and-dermatoscopic-features-of-scalp-nevi-in-adults/">The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>TrichoScan: Digital Hair Analysis for Modern Dermatology </title>
		<link>https://molemaxsystems.com/trichoscan-digital-hair-analysis-for-modern-dermatology/</link>
		
		<dc:creator><![CDATA[keshab]]></dc:creator>
		<pubDate>Sun, 16 Aug 2026 08:09:21 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=11248</guid>

					<description><![CDATA[<p>Hair loss affects millions of people worldwide and represents one of the most frequently presenting concerns in dermatology clinics. Despite its prevalence, accurate and objective assessment of hair loss has...</p>
<p>The post <a href="https://molemaxsystems.com/trichoscan-digital-hair-analysis-for-modern-dermatology/">TrichoScan: Digital Hair Analysis for Modern Dermatology </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Hair loss affects millions of people worldwide and represents one of the most frequently presenting concerns in dermatology clinics. Despite its prevalence, accurate and objective assessment of hair loss has historically relied on subjective visual examination, manual counting methods, and clinician experience. These approaches are inconsistent, time-consuming, and difficult to reproduce across multiple visits or practitioners.&nbsp;</p>



<p class="wp-block-paragraph">The demand for objective, quantifiable hair loss assessment has grown significantly as treatment options have expanded and patients expect measurable evidence of treatment progress. <a href="https://molemaxsystems.com/trichoscan-software/" target="_blank" rel="noreferrer noopener">TrichoScan Software</a> addresses this need directly, providing dermatologists, trichologists, and hair restoration clinics with a computer-assisted digital hair analysis platform that delivers reproducible, evidence-based clinical data. This article provides a comprehensive guide to TrichoScan technology, its clinical applications, and how it supports modern dermatology practice.&nbsp;</p>



<h2 class="wp-block-heading"><strong>What Is TrichoScan?</strong>&nbsp;</h2>



<p class="wp-block-paragraph">TrichoScan is a computer-assisted digital hair analysis software system designed for objective measurement of key hair growth parameters. It uses high-resolution scalp images captured through digital imaging systems to automatically identify, count, and measure individual hair follicles and shafts across a defined scalp area.&nbsp;</p>



<p class="wp-block-paragraph">Unlike traditional visual assessment or manual trichogram methods, TrichoScan provides quantitative clinical data that is consistent, reproducible, and directly comparable across multiple patient visits. This makes it particularly valuable for monitoring treatment response over time, where small but clinically significant changes in hair density or growth rate must be detected reliably.&nbsp;</p>



<p class="wp-block-paragraph">Modern versions of TrichoScan incorporate AI-assisted image analysis to improve detection accuracy, reduce operator variability, and increase workflow efficiency. Available through <a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">MoleMax Systems</a>, TrichoScan integrates into existing digital dermatology workflows alongside skin imaging and dermoscopy solutions.&nbsp;</p>



<h2 class="wp-block-heading"><strong>How Does TrichoScan Work?</strong>&nbsp;</h2>



<p class="wp-block-paragraph">TrichoScan follows a structured, repeatable assessment process that ensures consistent results across patient visits and clinical operators.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Step 1: Select the Assessment Area</strong>&nbsp;</h3>



<p class="wp-block-paragraph">A standardised assessment area on the scalp is selected and marked to ensure the same region is imaged at each subsequent visit. Standardisation of the assessment site is critical for accurate longitudinal comparison.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Step 2: Prepare the Scalp Area</strong>&nbsp;</h3>



<p class="wp-block-paragraph">The selected area is prepared by clipping hair to a uniform length. This standardises hair shaft length across the assessment area and ensures accurate automated counting and measurement.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Step 3: Capture High-Resolution Images</strong>&nbsp;</h3>



<p class="wp-block-paragraph">High-resolution scalp images are captured using a digital imaging system such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noreferrer noopener">MoleMax HD</a>, which provides the image quality required for accurate automated analysis.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Step 4: Automated Hair Analysis</strong>&nbsp;</h3>



<p class="wp-block-paragraph">TrichoScan&#8217;s automated image analysis algorithms process the captured images, identifying and measuring individual hair follicles and shafts. The software distinguishes between terminal and vellus hairs, identifies hair growth phases, and calculates key measurement parameters across the assessment area.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Step 5: Generate Quantitative Reports</strong>&nbsp;</h3>



<p class="wp-block-paragraph">TrichoScan generates standardised clinical reports containing objective measurement data. These reports are stored in the patient record and used for direct comparison at subsequent visits, supporting evidence-based clinical decision-making and patient communication.&nbsp;</p>



<p class="wp-block-paragraph">Key measurements generated by TrichoScan include:&nbsp;</p>



<ul class="wp-block-list">
<li>Hair density (hairs per cm²)&nbsp;</li>
</ul>



<ul class="wp-block-list">
<li>Hair diameter (micrometres)&nbsp;</li>
</ul>



<ul class="wp-block-list">
<li>Hair growth rate (mm per day)&nbsp;</li>
</ul>



<ul class="wp-block-list">
<li>Anagen to telogen ratio&nbsp;</li>
</ul>



<ul class="wp-block-list">
<li>Terminal to vellus hair ratio&nbsp;</li>
</ul>



<ul class="wp-block-list">
<li>Cumulative hair thickness index&nbsp;</li>
</ul>



<h2 class="wp-block-heading"><strong>Key Features of TrichoScan</strong>&nbsp;</h2>



<p class="wp-block-paragraph"><strong>AI-Powered Image Analysis</strong>: TrichoScan uses AI-assisted algorithms to automatically detect and measure hair follicles and shafts, reducing operator variability and improving detection accuracy across diverse scalp types and hair colours.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Automated Hair Counting:</strong> Manual hair counting is eliminated. TrichoScan automatically counts hairs within the defined assessment area, producing consistent counts that are unaffected by clinician fatigue or observer bias.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Hair Density Measurement</strong>: Hair density is measured objectively in hairs per square centimetre, providing a clinically meaningful baseline and enabling precise monitoring of density changes in response to treatment.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Longitudinal Treatment Tracking:</strong> Patient images and measurements are stored in a structured digital record. At each follow-up visit, new measurements are automatically compared with baseline data, generating clear visual and quantitative evidence of treatment response.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Standardised Reporting:</strong> TrichoScan generates standardised reports suitable for clinical records, patient communication, and research documentation. Reports include measurement summaries, comparative data across visits, and visual image overlays.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Reproducible Clinical Results</strong>: Standardised image capture and automated analysis ensure that results are reproducible regardless of which clinician performs the assessment, supporting consistency in multi-practitioner settings.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Digital Patient Records:</strong> All images, measurements, and reports are stored digitally within the patient record, supporting efficient retrieval, longitudinal comparison, and audit-ready documentation.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Clinical Applications of TrichoScan</strong>&nbsp;</h2>



<p class="wp-block-paragraph">TrichoScan supports assessment and monitoring across a broad range of hair loss conditions and clinical scenarios.&nbsp;</p>



<figure class="wp-block-image size-full"><img fetchpriority="high" decoding="async" width="992" height="517" src="https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan.png" alt="Trichoscan" class="wp-image-7541" srcset="https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan.png 992w, https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan-300x156.png 300w, https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan-768x400.png 768w, https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan-600x313.png 600w, https://molemaxsystems.com/wp-content/uploads/2024/12/TrichoScan-400x208.png 400w" sizes="(max-width: 992px) 100vw, 992px" /></figure>



<h3 class="wp-block-heading"><strong>Androgenetic Alopecia</strong>&nbsp;</h3>



<p class="wp-block-paragraph">Androgenetic alopecia is the most common cause of hair loss in both men and women. TrichoScan provides objective measurement of miniaturisation progression, terminal-to-vellus hair ratio, and density changes, enabling earlier detection of disease progression and more accurate monitoring of treatment response to medications such as finasteride and minoxidil.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Alopecia Areata</strong>&nbsp;</h3>



<p class="wp-block-paragraph">In alopecia areata, TrichoScan supports monitoring of regrowth patterns within affected patches, assessment of new follicular activity, and quantification of treatment response to corticosteroids, immunotherapy, and newer biological agents.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Telogen Effluvium</strong>&nbsp;</h3>



<p class="wp-block-paragraph">Telogen effluvium presents with diffuse shedding that is difficult to quantify objectively. TrichoScan&#8217;s anagen-to-telogen ratio measurement provides a direct, reproducible index of the proportion of follicles in the shedding phase, supporting both diagnosis and monitoring of recovery.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Hair Transplant Planning and Monitoring</strong>&nbsp;</h3>



<p class="wp-block-paragraph">Hair transplant surgeons use TrichoScan to assess donor area density before surgery, plan graft numbers with precision, and monitor transplanted follicle growth and survival rates post-procedure. Objective density measurements at baseline and follow-up provide legally and clinically defensible documentation of outcomes.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Post-Treatment Monitoring</strong>&nbsp;</h3>



<p class="wp-block-paragraph">For all hair loss conditions, TrichoScan provides the objective evidence needed to assess treatment effectiveness over time. Changes in hair density, diameter, and growth rate that are imperceptible to visual examination are reliably detected and documented through repeated TrichoScan assessments.&nbsp;</p>



<h3 class="wp-block-heading"><strong>Clinical Research Studies</strong>&nbsp;</h3>



<p class="wp-block-paragraph">TrichoScan&#8217;s standardised, reproducible measurement methodology makes it suitable for use in clinical trials and research studies evaluating new hair loss treatments. Its AI-assisted analysis reduces inter-observer variability, improving the reliability of research data.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Benefits of TrichoScan for Dermatology Clinics</strong>&nbsp;</h2>



<p class="wp-block-paragraph"><strong>Objective Diagnosis Support:</strong> TrichoScan replaces subjective visual assessment with quantitative clinical data, improving diagnostic confidence and supporting evidence-based clinical decision-making.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Improved Patient Communication</strong>: Visual reports showing before-and-after images and quantitative measurement comparisons are powerful tools for patient education and treatment adherence. Patients who can see objective evidence of improvement are more likely to continue treatment.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Quantifiable Treatment Outcomes:</strong> The ability to demonstrate measurable treatment outcomes differentiates clinics that use TrichoScan from those relying on visual assessment alone. This supports stronger patient outcomes, better retention, and enhanced clinic reputation.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Time-Saving Clinical Workflow</strong>: Automated image analysis and report generation reduce the time required per assessment compared with manual counting methods. This supports higher patient throughput without compromising assessment quality.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Enhanced Patient Confidence:</strong> Patients presenting with hair loss concerns are often anxious and uncertain about treatment prospects. Objective baseline measurements and clear progress reports build trust and confidence in clinical management.&nbsp;</p>



<p class="wp-block-paragraph"><strong>Comprehensive Documentation</strong>: Standardised digital records support clinical governance, audit requirements, medico-legal documentation, and continuity of care across clinical team members.&nbsp;</p>



<h2 class="wp-block-heading"><strong>TrichoScan vs Traditional Hair Assessment Methods</strong>&nbsp;</h2>



<figure class="wp-block-table"><table class="has-fixed-layout"><tbody><tr><td><strong>Method</strong>&nbsp;&nbsp;</td><td><strong>Accuracy</strong>&nbsp;&nbsp;</td><td><strong>Reproducibility</strong>&nbsp;&nbsp;</td><td><strong>Documentation</strong>&nbsp;&nbsp;</td><td><strong>Monitoring Capability</strong>&nbsp;&nbsp;</td></tr><tr><td>Visual examination&nbsp;&nbsp;</td><td>Low&nbsp;&nbsp;</td><td>Poor&nbsp;&nbsp;</td><td>None&nbsp;</td><td>Subjective&nbsp;&nbsp;</td></tr><tr><td>Hair pull test&nbsp;&nbsp;</td><td>Low&nbsp;&nbsp;</td><td>Poor&nbsp;&nbsp;</td><td>None&nbsp;</td><td>Limited&nbsp;&nbsp;</td></tr><tr><td>Traditional trichogram&nbsp;&nbsp;</td><td>Moderate&nbsp;&nbsp;</td><td>Moderate&nbsp;&nbsp;</td><td>Partial&nbsp;&nbsp;</td><td>Limited&nbsp;&nbsp;</td></tr><tr><td>TrichoScan digital analysis&nbsp;&nbsp;</td><td>High&nbsp;&nbsp;</td><td>Excellent&nbsp;&nbsp;</td><td>Comprehensive&nbsp;&nbsp;</td><td>Full longitudinal tracking&nbsp;&nbsp;</td></tr></tbody></table></figure>



<p class="wp-block-paragraph">Traditional visual scalp examination remains the most widely used initial assessment approach but provides no quantitative data and is highly dependent on individual clinician experience. The hair pull test gives a gross indication of active shedding but provides no density or growth rate data.&nbsp;</p>



<p class="wp-block-paragraph">The traditional trichogram involves manually plucking hairs for microscopic analysis, which is uncomfortable for patients, provides limited density information, and is difficult to reproduce accurately across different operators or time points.&nbsp;</p>



<p class="wp-block-paragraph"><a href="https://molemaxsystems.com/trichoscan-software/" target="_blank" rel="noreferrer noopener">TrichoScan Software</a> addresses all of these limitations through automated image analysis, standardised assessment protocols, and comprehensive digital reporting. It was specifically developed to provide a more reproducible and less subjective hair assessment process, and its clinical utility has been validated across multiple published research studies.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Why Dermatology Clinics Choose TrichoScan</strong>&nbsp;</h2>



<p class="wp-block-paragraph">Clinics that adopt TrichoScan report improvements across multiple dimensions of their hair loss assessment workflow. Evidence-based measurement data supports stronger clinical decision-making, clearer patient communication, and more defensible documentation of treatment outcomes.&nbsp;</p>



<p class="wp-block-paragraph">The ability to track treatment response objectively over months and years is particularly valuable in conditions like androgenetic alopecia, where changes are gradual and difficult to perceive without quantitative measurement. TrichoScan makes these changes visible and documentable, supporting both clinical and commercial outcomes for the practice.&nbsp;</p>



<p class="wp-block-paragraph">Integration with <a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">digital skin imaging solutions</a> from MoleMax Systems allows clinics to combine hair analysis with broader dermatological imaging capabilities, creating a comprehensive digital dermatology workflow within a single practice environment.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Why Buy TrichoScan from MoleMax Systems?</strong>&nbsp;</h2>



<p class="wp-block-paragraph"><a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">MoleMax Systems</a>, a division of Macquarie Medical Systems, has supported dermatology clinics, hair restoration practices, and medical research institutions with advanced digital imaging solutions for decades. As an established provider of <a href="https://molemaxsystems.com/" target="_blank" rel="noreferrer noopener">dermatology imaging software</a> and hardware, MoleMax offers TrichoScan with full implementation support, clinical training, and ongoing technical assistance.</p>



<p class="wp-block-paragraph">The MoleMax team understands the clinical environment in which TrichoScan is used and provides support tailored to the specific needs of dermatology practices, trichology clinics, and hair transplant centres. Combined with hardware solutions such as the <a href="https://molemaxsystems.com/product-molemax-hd/" target="_blank" rel="noreferrer noopener">MoleMax HD</a> digital imaging system, TrichoScan becomes part of a fully integrated digital dermatology and hair analysis platform.&nbsp;</p>



<p class="wp-block-paragraph">Purchasing TrichoScan through MoleMax Systems ensures access to Australian healthcare expertise, local warranty and support, and a team with direct experience in clinical dermatology and hair analysis technology.&nbsp;</p>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/trichoscan-digital-hair-analysis-for-modern-dermatology/">TrichoScan: Digital Hair Analysis for Modern Dermatology </a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>One Clue, Two Outcomes: Benign vs Malignant Through Dermoscopy</title>
		<link>https://molemaxsystems.com/one-clue-two-outcomes-benign-vs-malignant-through-dermoscopy/</link>
		
		<dc:creator><![CDATA[molemax]]></dc:creator>
		<pubDate>Mon, 09 Feb 2026 01:35:32 +0000</pubDate>
				<category><![CDATA[Dermoscopy Techniques & Clinical Studies]]></category>
		<category><![CDATA[dermoscopy]]></category>
		<category><![CDATA[skin cancer]]></category>
		<guid isPermaLink="false">https://molemaxsystems.com/?p=9119</guid>

					<description><![CDATA[<p>Dermoscopy reveals differences between benign and malignant lesions</p>
<p>The post <a href="https://molemaxsystems.com/one-clue-two-outcomes-benign-vs-malignant-through-dermoscopy/">One Clue, Two Outcomes: Benign vs Malignant Through Dermoscopy</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6af74c5e8cc11"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone "  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element " >
	<p>Patricija Girštautė, Melita Virpšaitė, Iveta Gylienė, Jorinta Jokubaitė, Tadas Raudonis</p>
<h3><strong>Introduction</strong></h3>
<p>Pyogenic granuloma is a common benign vascular lesion that can clinically and dermoscopically imitate melanoma and other tumors [1]. In our case, pyogenic granuloma and nodular melanoma exhibited dermoscopic similarities. Some dermoscopic patterns, which include characteristics such as a yellow collarette, a reddish homogenous area, and the presence of white rail lines, can aid in diagnosing pyogenic granuloma [12]. Even though pyogenic granuloma is benign, histology is still necessary, especially in cases where vas-cular structures are present, as melanoma cannot be ruled out [1,3].</p>
<p>To read this article <a href="https://dpcj.org/index.php/dpc/article/view/5780/3261" target="_blank" rel="noopener">please click here</a>.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
<div class="molemax-categories-injected"><ul class="molemax-cat-list"><li><a href="https://molemaxsystems.com/blog">ALL</a></li><li><a href="https://molemaxsystems.com/category/clinical-workflow-documentation/">CLINICAL WORKFLOW &AMP; DOCUMENTATION</a></li><li><a href="https://molemaxsystems.com/category/dermoscopy-techniques-clinical-studies/">DERMOSCOPY TECHNIQUES &AMP; CLINICAL STUDIES</a></li><li><a href="https://molemaxsystems.com/category/digital-dermoscopy-skin-imaging/">DIGITAL DERMOSCOPY &AMP; SKIN IMAGING</a></li><li><a href="https://molemaxsystems.com/category/evidence-research/">EVIDENCE &AMP; RESEARCH</a></li><li><a href="https://molemaxsystems.com/category/mole-mapping-lesion-tracking/">MOLE MAPPING &AMP; LESION TRACKING</a></li><li><a href="https://molemaxsystems.com/category/molemax-hd-total-body-mapping/">MOLEMAX HD &AMP; TOTAL BODY MAPPING</a></li><li><a href="https://molemaxsystems.com/category/research-clinical-evidence/">RESEARCH &AMP; CLINICAL EVIDENCE</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-detection-diagnosis/">SKIN CANCER DETECTION &AMP; DIAGNOSIS</a></li><li><a href="https://molemaxsystems.com/category/skin-cancer-research-evidence/">SKIN CANCER RESEARCH &AMP; EVIDENCE</a></li></ul></div><p>The post <a href="https://molemaxsystems.com/one-clue-two-outcomes-benign-vs-malignant-through-dermoscopy/">One Clue, Two Outcomes: Benign vs Malignant Through Dermoscopy</a> appeared first on <a href="https://molemaxsystems.com">MoleMax Systems</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
